These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28068865)

  • 41. Homocysteine, folate, and cardiovascular disease.
    Ward M
    Int J Vitam Nutr Res; 2001 May; 71(3):173-8. PubMed ID: 11582839
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Where are we standing in homocysteine research?
    Herrmann W
    Clin Chem Lab Med; 2003 Nov; 41(11):1389-91. PubMed ID: 14656015
    [No Abstract]   [Full Text] [Related]  

  • 43. Homocysteine in lipoprotein apheresis patients--retrospective data analysis in apheresis center of a university hospital.
    Tselmin S; Rodionov RN; Müller G; Bornstein S; Julius U
    Atheroscler Suppl; 2013 Jan; 14(1):123-8. PubMed ID: 23357153
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.
    Seshadri S; Beiser A; Selhub J; Jacques PF; Rosenberg IH; D'Agostino RB; Wilson PW; Wolf PA
    N Engl J Med; 2002 Feb; 346(7):476-83. PubMed ID: 11844848
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Homocysteine. The cardiovascular risk factor of the next millennium?].
    Suárez García I; Gómez Cerezo JF; Ríos Blanco JJ; Barbado Hernández FJ; Vázquez Rodríguez JJ
    An Med Interna; 2001 Apr; 18(4):211-7. PubMed ID: 11496543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Homocysteine and Alzheimer's disease.
    Leboeuf R
    J Am Diet Assoc; 2003 Mar; 103(3):304-7. PubMed ID: 12616250
    [No Abstract]   [Full Text] [Related]  

  • 47. [Homocysteine, folic acid, group B vitamins and cardiovascular risk].
    Blacher J; Czernichow S; Horrellou MH; Conad J; David P; Chadefaux-Vekemans B; Ankria A; Galan P; Hercberg S; Ducimetière P
    Arch Mal Coeur Vaiss; 2005 Feb; 98(2):145-52. PubMed ID: 15787307
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of homocysteine on cortical perfusion and cognitive decline in mild Alzheimer's dementia.
    Huang CW; Chang WN; Huang SH; Lui CC; Chen NC; Chang YT; Lee CC; Chang CC; Chang AY
    Eur J Neurol; 2013 Aug; 20(8):1191-7. PubMed ID: 23581395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Measuring the homocysteine level.
    Scott PM
    JAAPA; 2005 Sep; 18(9):57. PubMed ID: 16184873
    [No Abstract]   [Full Text] [Related]  

  • 50. The worldwide challenge of the dementias: a role for B vitamins and homocysteine?
    Smith AD
    Food Nutr Bull; 2008 Jun; 29(2 Suppl):S143-72. PubMed ID: 18709889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Homocysteine and cardiovascular disease: a review of current recommendations for screening and treatment.
    Chamberlain KL
    J Am Acad Nurse Pract; 2005 Mar; 17(3):90-5. PubMed ID: 15748221
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Homocysteine: the latest risk factor for heart disease.
    Reeder SJ; Hoffmann RL; Magdic KS; Rodgers JM
    Dimens Crit Care Nurs; 2000; 19(1):22-8. PubMed ID: 10876482
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Homocysteine metabolism and its role in pathology].
    Pentiuk OO; Lutsiuk MB; Andrushko II; Postovitenko KP
    Ukr Biokhim Zh (1999); 2003; 75(1):5-17. PubMed ID: 14574730
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients.
    Suliman ME; Lindholm B; Bárány P; Qureshi AR; Stenvinkel P
    Semin Dial; 2007; 20(6):523-9. PubMed ID: 17991198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relation between homocysteine levels and development of Alzheimer's disease in mild cognitive impairment patients.
    Annerbo S; Wahlund LO; Lökk J
    Dement Geriatr Cogn Disord; 2005; 20(4):209-14. PubMed ID: 16088136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Homocysteine in neuropsychiatric disorders of the elderly.
    Reutens S; Sachdev P
    Int J Geriatr Psychiatry; 2002 Sep; 17(9):859-64. PubMed ID: 12221661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship of cognitive function with B vitamin status, homocysteine, and tissue factor pathway inhibitor in cognitively impaired elderly: a cross-sectional survey.
    Kim G; Kim H; Kim KN; Son JI; Kim SY; Tamura T; Chang N
    J Alzheimers Dis; 2013; 33(3):853-62. PubMed ID: 23042212
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hyperhomocysteinemia in patients with dementia].
    Graban A
    Neurol Neurochir Pol; 2003; 37(4):879-87. PubMed ID: 14746246
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Homocysteine, vitamin B-12, folic acid and the cognitive decline in the elderly].
    Smach MA; Naffeti S; Charfeddine B; Ben Abdallah J; Othmen LB; Letaef A; Limem K
    Pathol Biol (Paris); 2013 Oct; 61(5):184-92. PubMed ID: 22647793
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging.
    Kado DM; Karlamangla AS; Huang MH; Troen A; Rowe JW; Selhub J; Seeman TE
    Am J Med; 2005 Feb; 118(2):161-7. PubMed ID: 15694902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.